References
- Alvaro-Meca A, Jimenez-Sousa MA, Micheloud D, et al. Epidemiological trends of sepsis in the twenty-first century (2000-2013): an analysis of incidence, mortality, and associated costs in Spain. Popul Health Metr. 2018;16:4.
- Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43:304–377.
- De Backer D, Orbegozo Cortes D, Donadello K, et al. Pathophysiology of microcirculatory dysfunction and the pathogenesis of septic shock. Virulence. 2014;5:73–79.
- Chan YL, Han ST, Li CH, et al. Transfusion of red blood cells to patients with sepsis. Int J Mol Sci. 2017;18:E1946.
- Soussi S, Deniau B, Ferry A, et al. Low cardiac index and stroke volume on admission are associated with poor outcome in critically ill burn patients: a retrospective cohort study. Ann Intensive Care. 2016;6:87.
- Sharma S, Sharma P, Tyler LN. Transfusion of blood and blood products: indications and complications. Am Fam Physician. 2011;83:719–724.
- Charlton M, Sims M, Coats T, et al. The microcirculation and its measurement in sepsis. J Intensive Care Soc. 2017;18:221–227.
- Moradi S, Jahanian-Najafabadi A, Roudkenar MH. Artificial blood substitutes: first steps on the long route to clinical utility. Clin Med Insights Blood Disord. 2016;9:33–41.
- Li Y, Yan D, Hao S, et al. Polymerized human placenta hemoglobin improves resuscitative efficacy of hydroxyethyl starch in a rat model of hemorrhagic shock. Artif Cells Nanomed Biotechnol. 2015;43:174–179.
- Patel MB, Feinstein AJ, Saenz AD, et al. Prehospital HBOC-201 after traumatic brain injury and hemorrhagic shock in swine. J Trauma. 2006;61:46–56.
- Li T, Yang G, Zhu Y, et al. Beneficial effects of novel cross-linked hemoglobin YQ23 on hemorrhagic shock in rats and pigs. J Surg Res. 2017;210:213–222.
- Liu L, Wu H, Zang J, et al. 4-Phenylbutyric acid reveals good beneficial effects on vital organ function via anti-endoplasmic reticulum stress in septic rats. Crit Care Med. 2016;44:e689–e701.
- Wu Y, Zhu Y, Chen XY, et al. Diversity of vascular reactivity and the treatment response in diabetic, hypertensive, hyperlipidemic, and healthy rats subjected to hemorrhagic shock. Shock. 2016;45:174–183.
- Zhang Z, Ji X. Quadratic function between arterial partial oxygen pressure and mortality risk in sepsis patients: an interaction with simplified acute physiology score. Sci Rep. 2016;6:35133.
- Zhu Y, Wu H, Wu Y, et al. Beneficial effect of intermedin 1-53 in septic shock rats: contributions of rho kinase and BKCA pathway-mediated improvement in cardiac function. Shock. 2016;46:557–565.
- Rivers EP, Yataco AC, Jaehne AK, et al. Oxygen extraction and perfusion markers in severe sepsis and septic shock: diagnostic, therapeutic and outcome implications. Curr Opin Crit Care. 2015;21:381–387.
- Zafrani L, Ergin B, Kapucu A, et al. Blood transfusion improves renal oxygenation and renal function in sepsis-induced acute kidney injury in rats. Crit Care 2016;20:406.
- Puskarich MA, Shapiro NI, Massey MJ, et al. Lactate clearance in septic shock is not a surrogate for improved microcirculatory flow. Acad Emerg Med. 2016;23:690–693.
- Carre JE, Orban JC, Re L, et al. Survival in critical illness is associated with early activation of mitochondrial biogenesis. Am J Respir Crit Care Med. 2010;182:745–751.
- Russell JA, Rush B, Boyd J. Pathophysiology of Septic Shock. Crit Care Clin. 2018;34:43–61.
- Erdogan S, Bosnak M. Using terlipressin in a pediatric patient with septic shock resistant to catecholamines. North Clin Istanb. 2017;4:283–287.
- Sinning C, Westermann D, Clemmensen P. Oxidative stress in ischemia and reperfusion: current concepts, novel ideas and future perspectives. Biomark Med. 2017;11:11031–11040.
- Granger DN, Kvietys PR. Reperfusion injury and reactive oxygen species: the evolution of a concept. Redox Biol. 2015;6:524–551.
- Jahr JS, Moallempour M, Lim JC. HBOC-201, hemoglobin glutamer-250 (bovine), Hemopure (Biopure Corporation). Expert Opin Biol Ther. 2008;8:1425–1433.
- Davis JM, El-Haj N, Shah NN, et al. Use of the blood substitute HBOC-201 in critically ill patients during sickle crisis: a three-case series. Transfusion. 2018;58:132–137.
- Natanson C, Kern SJ, Lurie P, et al. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis. JAMA. 2008;299:2304–2312.
- McNeil JD, Propper B, Walker J, et al. A bovine hemoglobin-based oxygen carrier as pump prime for cardiopulmonary bypass: reduced systemic lactic acidosis and improved cerebral oxygen metabolism during low flow in a porcine model. J Thorac Cardiovasc Surg. 2011;142:411–417.
- Freilich D, Pearce LB, Pitman A, et al. HBOC-201 vasoactivity in a phase III clinical trial in orthopedic surgery subjects–extrapolation of potential risk for acute trauma trials. J Trauma. 2009;66:365–376.
- Saxena R, Wijnhoud AD, Carton H, et al. Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke. Stroke. 1999;30:993–996.
- Mongan PD, Moon-Massat PF, Rentko V, et al. Regional blood flow after serial normovolemic exchange transfusion with HBOC-201 (Hemopure) in anesthetized swine. J Trauma. 2009;67:51–60.
- Bian Y, Rong Z, Chang TM. Polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase: a novel biotechnology-based blood substitute that transports both oxygen and carbon dioxide and also acts as an antioxidant. Artif Cells Blood Substit Immobil Biotechnol. 2011;39:127–136.
- Chen G, Duan Y, Liu J, et al. Antioxidant effects of vitamin C on hemoglobin-based oxygen carriers derived from human cord blood. Artif Cells Nanomed Biotechnol. 2016;44:56–61.